Fomepizole clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How each study uses Fomepizole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 4 Dec 1997 · ANTIZOL · NDA 020696 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Amgen (1) · University of Utah (1) · University of Arizona (1) · Richard Dart, MD, PhD (1)
Studies
Open first, then newest update. How each study uses Fomepizole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen OverdoseTerminatedPhase 2Richard Dart, MD, PhDNCT05517668Written as Intravenous infusion of Fomepizole (4-MP)
- Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol MetabolismCompletedPhase 2AmgenNCT00661141Written as Antizol
- Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyCompletedPhase 1University of UtahNCT00346853Written as 4-Methylpyrazole
- 4-methylpyrazole and Acetaminophen MetabolismCompletedEarly Phase 1University of ArizonaNCT03878693Written as Fomepizole
Codes
What other systems call Fomepizole · ClinicalTrials.gg INT006774
- MeSH (NLM) D000077604FomepizoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 83LCM6L2BYFOMEPIZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 15226Confirmed FDA, Wikidata
- Wikidata Q416410fomepizoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47538FomepizoleOne source FDA
- DrugBank DB01213One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077604 | Fomepizole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 83LCM6L2BY | FOMEPIZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 15226 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416410 | fomepizole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47538 | Fomepizole | One source FDA |
| DrugBank | DB01213 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.